Olig 2 Lineage Cells Derived From ES Cells
来自 ES 细胞的 Olig 2 谱系细胞
基本信息
- 批准号:7217978
- 负责人:
- 金额:$ 30.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AchievementAntibodiesAstrocytesBMP2 geneBMP4Basic ScienceBiological ProcessCell CountCell LineageCell TransplantationCell divisionCell physiologyCellsCiliary Neurotrophic FactorCommitDataDevelopmentEGF geneES Cell LineErinaceidaeFGF8 geneFibroblast Growth Factor 2Fibroblast Growth Factor 8Gene ExpressionGene Expression ProfilingGenesGlial DifferentiationGoalsGreen Fluorescent ProteinsIn VitroKnock-in MouseLearningLifeMapsMeasuresMitogensModelingMotor NeuronsMultipotent Stem CellsNervous system structureNeurogliaNeuronal DifferentiationNeuronsNumbersOligodendrogliaPathway interactionsPlatelet-Derived Growth FactorPopulationProtocols documentationReagentResearchReverse Transcriptase Polymerase Chain ReactionSHH geneSerumSignal TransductionSourceSpecific qualifier valueStagingStaining methodStainsStem cellsSystemTestingTimeTo specifyTransplantationTretinoinWorkautocrinebasebone morphogenetic protein 4embryonic stem cellgenetic manipulationgenetically modified cellsin vivoinsightmRNA Expressionmembernerve stem cellneurodevelopmentpractical applicationprecursor cellprogenitorreceptorrelating to nervous systemresearch studyresponsetool
项目摘要
The long-term goal of this research is two-fold. One is to gain insights into the mechanisms that control fate choice in the early developing nervous system. The principal tool is ES cells differentiated in culture to produce a model of normal CNS development. The model is powerful because large numbers of cells are produced and because gone targeting and other genetic manipulations are feasible. Using the advantages of this model we will investigate how early neural precursor cells choose a fate defined by expression of the Olig2 gene. Cells from this pathway eventually differentiate into motor neurons and oligodendrocytes. Retinoic acid and sonic hedgehog interact to specify na'ive cells to follow this fate. We will learn how these 2
pathways interact. Specified cells are capable of cell division. We have discovered how to induce dividing cells to undergo long-term division. Even though they divide continuously the cells keep their identity as members of the Olig2 lineage. Our working hypothesis is that normal early neural stem cells are indeed capable of sustained division. If true, this will provide large numbers of specified neural stem cells for many applications. The final stage of stem cell life is differentiation. We will investigate signals that are responsible for differentiation of Olig2 pathway cells. We have already discovered how to efficiently differentiate these cells into astrocytes and oligodendrocytes and will extend this work to neurons. The second long-term goal is to harness the potential that ES cells have for neural transplantation. While the
potential is real, practical application demands major advances in basic understanding. It is theoretically possible to direct ES cells to coordinately differentiate into any single type of neural cell. Achievement of this goal even for a few cell lineages would open up new opportunities in transplantation research. Results of this project will provide proof-of-principle for this idea. A combination of instructive and selective strategies is being applied to the goal of getting pure populations. Cells from each stage of the Olig2 lineage will be available in large numbers and at high purity. Lessons learned from this lineage will be applicable to others. One strong possibility is that genetically engineered cells will be most efficacious in transplantation. The ES
cell-based system is ideally suited to providing genetically engineered cells.
The long-term goal of this research is two-fold. One is to gain insights into the mechanisms that control fate choice in the early developing nervous system. The principal tool is ES cells differentiated in culture to produce a model of normal CNS development.该模型之所以强大,是因为产生了大量细胞,并且目标定位和其他基因操作都是可行的。 Using the advantages of this model we will investigate how early neural precursor cells choose a fate defined by expression of the Olig2 gene. Cells from this pathway eventually differentiate into motor neurons and oligodendrocytes. Retinoic acid and sonic hedgehog interact to specify na'ive cells to follow this fate. We will learn how these 2
路径相互作用。 Specified cells are capable of cell division.我们已经发现了如何诱导分裂细胞进行长期分裂。 Even though they divide continuously the cells keep their identity as members of the Olig2 lineage. Our working hypothesis is that normal early neural stem cells are indeed capable of sustained division. If true, this will provide large numbers of specified neural stem cells for many applications. The final stage of stem cell life is differentiation. We will investigate signals that are responsible for differentiation of Olig2 pathway cells. We have already discovered how to efficiently differentiate these cells into astrocytes and oligodendrocytes and will extend this work to neurons. The second long-term goal is to harness the potential that ES cells have for neural transplantation.虽然
潜力是真实的,实际应用需要在基本理解上取得重大进展。理论上,引导 ES 细胞协调分化成任何单一类型的神经细胞是可能的。即使对于少数细胞谱系而言,这一目标的实现也将为移植研究开辟新的机会。 Results of this project will provide proof-of-principle for this idea.指导性和选择性策略的结合正在被应用于获得纯种群的目标。来自 Olig2 谱系各个阶段的细胞将大量且高纯度地提供。从这一血统中吸取的教训将适用于其他血统。一种很大的可能性是基因工程细胞在移植中最有效。 ES
基于细胞的系统非常适合提供基因工程细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID I GOTTLIEB其他文献
DAVID I GOTTLIEB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID I GOTTLIEB', 18)}}的其他基金
ROLE OF THE MED1 SUBUNIT OF MEDIATOR CO-ACTIVATOR COMPLEX IN NEURAL STEM CELLS
介导共激活复合物的 MED1 亚基在神经干细胞中的作用
- 批准号:
8282246 - 财政年份:2012
- 资助金额:
$ 30.19万 - 项目类别:
Olig 2 Lineage Cells Derived From ES Cells
来自 ES 细胞的 Olig 2 谱系细胞
- 批准号:
6774425 - 财政年份:2004
- 资助金额:
$ 30.19万 - 项目类别:
Olig 2 Lineage Cells Derived From ES Cells
来自 ES 细胞的 Olig 2 谱系细胞
- 批准号:
7022208 - 财政年份:2004
- 资助金额:
$ 30.19万 - 项目类别:
Olig 2 Lineage Cells Derived From ES Cells
来自 ES 细胞的 Olig 2 谱系细胞
- 批准号:
6851796 - 财政年份:2004
- 资助金额:
$ 30.19万 - 项目类别:
Olig 2 Lineage Cells Derived From ES Cells
来自 ES 细胞的 Olig 2 谱系细胞
- 批准号:
7421032 - 财政年份:2004
- 资助金额:
$ 30.19万 - 项目类别:
ES CELL DERIVED LINEAGES--A NEW ENABLING TECHNOLOGY
ES 细胞衍生谱系——一种新的使能技术
- 批准号:
6056731 - 财政年份:1997
- 资助金额:
$ 30.19万 - 项目类别:
ES CELL DERIVED LINEAGES--A NEW ENABLING TECHNOLOGY
ES 细胞衍生谱系——一种新的使能技术
- 批准号:
2772049 - 财政年份:1997
- 资助金额:
$ 30.19万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 30.19万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 30.19万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 30.19万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 30.19万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 30.19万 - 项目类别:














{{item.name}}会员




